Newsroom

Industry News

18 Dec

Anavex to Present at Biotech Showcase 2015 in San Francisco

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of cancer, will present at Biotech Showcase 2015 on Monday January 12, 2015 at 2:00pm PST. The...

Read more

17 Dec

United Health Products Announces Australian Sales Update

United Health Products, Inc. (OTCQB: UEEC) announced today that the Company has received an additional stocking order for the HemoStyp® gauze products from its Australian distributor, Critical Health Products Pty Ltd. and distribution partner for Australia, Westcoast Surgical & Medical Supplies for 2014. Critical Health Products has also secured future...

Read more

17 Dec

Prima BioMed Completes Immutep Acquisition

Prima BioMed Ltd (“Prima” or the “Company”) announces that the acquisition of Immutep SA (“Immutep”), the French privately owned biopharmaceutical company in the rapidly growing field of Immuno-Oncology, has been completed. Prima also announces that Professor Frédéric Triebel has joined the Company as its new Chief Scientific Officer and...

Read more

17 Dec

SurePure Announces commercial trials of SurePure’s Photopurification Technology as an Alternative to Dairy Pasteurization in India

SurePure, Inc. (SURP), a global leader in liquid photopurification, announced that, following from the Indian Food Safety regulatory body (FSSAI) approval the use of SurePure’s proprietary photopurification technology as an alternative process to thermal pasteurization for milk and other dairy products, it is conducting commercial trials with key dairy...

Read more

17 Dec

Inovio Pharmaceuticals, Inc. (INO) announced today the appointment of Zane Yang, M.D. as Vice President, Clinical Development, Oncology. In this position, he will be responsible for advancing Inovio’s oncology portfolio of DNA immunotherapies through clinical trials to commercialization. He will report to Dr. Mark Bagarazzi, Inovio’s Chief Medical Officer

Inovio is planning a phase III trial for its immunotherapy for a pre-cancer, known as cervical dysplasia, which met its endpoints in a recent phase II trial. The company is in or about to move into phase I trials for numerous cancers including prostate, cervical, breast, lung, head and...

Read more

16 Dec

SurePure Enters distribution agreement with Spanish Distributor

SurePure, Inc. (OTCBB: SURP) a global leader in liquid photopurification, is pleased to announce Atlantica de Suministros, Obras y Servicios, s.l. (“Atlantica”) as SurePure’s distributor in Spain. Atlantica carefully selects technologies that are appropriate to its customers and that are both cost effective and reduce environmental impacts. Guy Kebble, CEO...

Read more

16 Dec

Lightlake Therapeutics Inc. Announces Licensing Deal With Adapt Pharma Limited Subsidiary

Lightlake Therapeutics Inc. (“Lightlake”) (LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has entered into a license agreement with Adapt Pharma Operations Limited (“Adapt”), a wholly owned subsidiary of Adapt Pharma Limited, an Ireland-based pharmaceutical company (“Adapt Pharma”). Pursuant...

Read more

Page 1 of 3612345...102030...Last »

Latest Tweets